Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lytic Cycle of Bacteriophages

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Root-like apical hard-tissue structure associated with apical periodontitis in an immature permanent tooth: a case report and literature review.

BMC oral health·2026

Same author

Automated analysis of effluents from nuclear facilities for <sup>55</sup>Fe and<sup>63</sup>Ni.

Journal of hazardous materials·2025

Same author

Robot-assisted autotransplantation of third molars in the maxilla: two case reports.

Frontiers in oral health·2025

Same author

A Synthetic Phage-Peptide Conjugate as a Potent Antibacterial Agent for <i>Pseudomonas aeruginosa</i> Infections.

ACS central science·2025

Same author

High doses of the galactooligosaccharides, 2'-fucosyllactose alleviate immunodeficiency in vitro and in vivo.

European journal of nutrition·2025

Same author

Real-Time <i>in Vivo</i> Bacterial Imaging by Computed Tomography and Fluorescence Using Phage-Gold Nanorod Bioconjugates as Contrast Agents.

ACS biomaterials science & engineering·2025

Same journal

A DLP-Printed 3D Bioceramplug Fabricated Using a Photocurable Negative Thermo-Responsive Bioceramic Slurry for Cranial Burr-Hole Repair.

ACS biomaterials science & engineering·2026

Same journal

A Microenvironment-Driven Peptide Nanoplatform Enhances Ferroptosis and Antiangiogenic Activity for Triple-Negative Breast Cancer Therapy.

ACS biomaterials science & engineering·2026

Same journal

A Dural Extracellular Matrix Hydrogel with Neural Stem Cells Improves Recovery from Traumatic Brain Injury in Mice.

ACS biomaterials science & engineering·2026

Same journal

Biomimetic 3D-Printed Resorbable Extracellular Matrix-Guided Bone Regeneration Membrane Based on a Gelatin Methacrylate/Alginate-Hydroxyapatite Composite for Maxillofacial Surgery.

ACS biomaterials science & engineering·2026

Same journal

Sequential Biofunctionalization of a Choline-Based Monomeric Ionic Liquid and Polymerized Ionic Liquid: A Route to Dual Anionic Drug Polymer Conjugates of Piperacillin-Tazobactam.

ACS biomaterials science & engineering·2026

Same journal

Retinoic Acid-Functionalized Chitosan Polycationic Conjugates for Integrated Melanoma Therapy and Antibacterial Infection Control.

ACS biomaterials science & engineering·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 9, 2025

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

Empowering Healthcare with Phage Display Technology.

Bingze Lyu¹, Haolin Zhou¹, Huijun Wang¹

¹Cellular Signaling Laboratory, International Research Center for Sensory Biology and Technology of MOST, Key Laboratory of Molecular Biophysics of MOE, College of Life Science and Technology, Huazhong University of Science and Technology, 430074 Wuhan, Hubei, China.

ACS Biomaterials Science & Engineering

|May 5, 2025

Summary

This summary is machine-generated.

Phage display technology identifies high-affinity ligands for diverse applications. Innovations enhance its potential in biomaterials, stem cell research, drug delivery, and diagnostics, empowering future healthcare solutions.

Keywords:

biomedical applications health molecular screening phage display technology

More Related Videos

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

Published on: February 16, 2014

Related Experiment Videos

Last Updated: May 9, 2025

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Using Phage Display to Develop Ubiquitin Variant Modulators for E3 Ligases

Published on: August 27, 2021

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Construction of Synthetic Phage Displayed Fab Library with Tailored Diversity

Published on: May 1, 2018

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

A Protocol for Phage Display and Affinity Selection Using Recombinant Protein Baits

Published on: February 16, 2014

Area of Science:

Biotechnology
Molecular Biology
Medical Research

Background:

Phage display technology, developed in 1985, is a molecular screening tool.
It enables the display of peptides or proteins on phage surfaces to identify high-affinity ligands.
This technology has broad applications in various biological fields.

Purpose of the Study:

To review the recent developments and applications of phage display technology.
To highlight its potential in empowering healthcare.
To discuss its advancements in diverse biological fields.

Main Methods:

Literature review of phage display technology applications.
Analysis of recent innovations and their impact.
Discussion of challenges and future therapeutic potential.

Main Results:

Phage display has identified peptides enhancing biomaterial biocompatibility and supporting stem cell functions.
Applications include targeted drug delivery, bacterial detection, and biomarker identification.
The technology shows promise for cancer treatments, including crossing the blood-brain barrier.

Conclusions:

Phage display technology offers significant potential for advancing healthcare.
Ongoing innovations are addressing challenges like peptide stability and immunogenicity.
Its continued development is expected to yield novel therapeutic and diagnostic tools.